Calcitonin levels do not decrease with weaning in chronic alcoholism

Thyroid

Volumn 17, Issue 3, 2007, Pages 213-217

  Vantyghem, M C ^a   Danel, T ^a   Marcelli Tourvieille, S ^a   Moriau, J ^a   Leclerc, L ^a   Cardot Bauters, C ^a   Docao, C ^a   Carnaille, B ^a   Wemeau, J L ^a   D'Herbomez, M ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALCITONIN; CALCIUM; GAMMA GLUTAMYLTRANSFERASE; GASTRIN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOLISM; ARTICLE; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE VOLUME; GASTRIN BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; SMOKING; THYROID NODULE;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; CALCITONIN; CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34147190858     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0216     Document Type: Article

References (41)

1. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera AJ 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829.
2. Niccoli P, Wion-Barbot N, Caron P, Henry JF, De Misco C, Saint-André JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 82:338-341.
3. Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Vierhapper H, Haas OA, Niederle B 1998 C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for calcitonin. Am J Surg Pathol 22:722-728.
4. Elisei R, Bottici V, Luchetti F, Di Coscio GC, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:4768-4769.
5. Miraillie E, Iacobone M, Sebag F, Henry JF 2004 Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of calcitonin. Eur J Surg Oncol 30:790-795.
6. Barbot N, Calmette C, Schuffenecker Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 78:114-120.
7. Baudin E, Bidart JM, Rougier P, Lazar V, Ruffie P, Ropers J, Ducreux M, Troalen F, Sabourin JC, Comoy E, Lasser P, DeBaere T, Schlumberger M 1999 Screening for mutiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors. J Clin Endocrinol Metab 84:187-191.
8. D'Herbomez M, Leclerc L, Vantyghem MC, Fourrier F, Proye C, Wemeau JL 2001 Clinical evaluation of a new sensitive calcitonin assay: study of specificity. Clin Chim Acta 311:149-155.
9. Niccoli P, Conte-Devolx B, Lejeune PJ, Carayon P, Henry JF, Roux F, Wion-Barbot N, Bigorgne JC 1996 Hypercalcitoninemia outside medullary thyroid carcinoma. Ann Endocrinol 57:15-21.
10. Guyetant S 2006 C-cell hyperplasia. Ann Endocrinol 6:190-197.
11. Deftos LJ, Weisman MH, Williams GH, Karpf DB, Frumar AM, Davidson BH, Parthemore JG, Judd HL 1980 Influence of age and sex on plasma calcitonin in human beings. New Engl J Med 302:1351-1353.
12. Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, Soregi G, Niederle B, Vierhapper H 1999 Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 9:943-947.
13. Albores-Saavedra J, Monforte H, Nadji M, Morales AR C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors 1988 Hum Pathol 19:795-799.
14. Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R, Bigorgne JC 1991 Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients. Ann Endocrinol 52:109-112.
15. Vantyghem MC, Pigny P, Leteurtre E, Leclerc L, Bauters C, Douillard C, D'Herbomez M, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M 2004 Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation. Thyroid 14: 842-847.
16. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr 2004 Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512-1525.
17. Bevilacka M, Dominguez LJ, Righini V, Valdes V, Toscano R, Sangaletti O, Vago T, Beldi G, Barella M, Bianch-Porro G 2005 Increased gastrin and calcitonin secretion after oral calcium or peptones administration in patients with hypercalciuria: a clue to an alteration in calcium-sensing receptor activity. J Clin Endocrinol Metab 90:1489-1494.
18. Livolsi VA, Feind CR, Lofergo P, Tashjian AH 1973 Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid in hyperparathyroidism. J Clin Endocrinol Metab 37:550-559.
19. Vlaeminck-Guillem V, D'Herbomez M, Pigny P, Fayard A, Bauters C, Wemeau JL 2001 Pseuhypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab 86:3091-3096.
20. Ergogan MF, Gullu S, Baskal N, Uyssal A.R, Kamel N, Erdogan G 1997 Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 82:897-899.
21. Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S, Abbruzzese A, Lupoli G 2002 Comparaison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Clin Chem 48:1505-1510.
22. Tommasi M, Brocchi A, Cappellini A, Raspanti S, Mannelli M 2001 False serum calcitonin high level using a non-competitive two-site IRMA. J Endocrinol Invest 24:356-360.
23. Bieglmayer, Niederle B, Vierhapper H 2002 Interference causes false high calcitonin levels with a commercial assay. J Endocrinol Invest 25:197.
24. Dymling JF, Ljunberg O, Hillyard CJ, Greenberg PB, Evans IM, MacIntyre I 1976 Whisky: a new provocative test for calcitonin secretion. Acta Endocrinol 82:500-509.
25. Kanis JA, Adams ND, Cechettini M, Luizetto G, Gaspar S, Heynen G 1979 Ethanol induced secretion of calcitonin in chronic renal disease Clin Endocrinol 10:155-161.
26. Williams GA, Bowser EN, Hargis GK, Kukreja SC, Shah JH, Vora NM, Henderson WJ 1978 Effects of ethanol on parathyroid hormone and calcitonin secretion in man Proc Soc Exp Biol Med 159:187-191.
27. Cohen SL, MacIntyre I, Grahame-Smith D, Walker JG 1973 Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid. Lancet 2(7839):1172-1173.
28. Eliasson M, Hagg E, Lundblad D, Karlsson R, Bucht E 1993 Influence of smoking and snuff use on electrolytes, adrenal and calcium regulating hormones. Acta Endocrinol 128:35-40.
29. Tabassian AR, Nylen ES, Giron AE, Snider RH, Cassidy MM, Becker KL 1988 Evidence for cigarette smoke-induced calcitonin secretion from lungs of man and hamster. Life Sci 42:2323-2329.
30. Henriksen JH, Schifter S, Moller S, Bendten F 2000 Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene-related peptide. Metabolism 49:47-52.
31. Bendtsen F, Schifter S, Henriksen JH 1991 Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol 12:118-123.
32. Ehlers CL, Somes C, Li TK, Lumeng L, Hwang BH, Jimenez P, Mathe AA Calcitonin gene-related peptide (CGRP) levels and alcohol 1999 Int J Neuropsychopharmacol 2:173-179.
33. Stoyanova II, Gulubova MV. 2000 Immunocytochemical study on the liver innervation in patients with cirrhosis. Acta Histochem 102:391-402.
34. Astaf'eva OV, Vinokurova LV, Petrakov AV, Banifatov PV. 2002 Hormonal regulation of calcium metabolism in chronic alcoholic pancreatitis [in Russian]. Eksp Klin Gastroenterol 1:72-74,192.
35. Sanchez JJ, del Pino Montes J, Martin Rodriguez M, Garcia Talavera JR, Calvo Andres JJ, Fermoso Garcia J 1989 Heterogeneity of calcitonin in liver cirrhosis [in Spanish]. Rev Clin Esp 185:235-239.
36. Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, Papatsibas G, Kontou-Kastellanou C, Moulakakis 2006 A. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol 18:525-530.
37. Seitz HK, Stickel F. 2006 Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387:349-360.
38. Li W, Hou L, Hua Z, Wang X. 2004 Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. FASEB J 18:1603-1605.
39. Fernandez S, Knopf MA, Shankar G, McGillis JP. 2003 Calcitonin gene-related peptide indirectly inhibits IL-7 responses in pre-β cells by introduction. Cell Immunol 226:67-77.
40. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J 2006 Cytokines and alcohol. Alcohol Clin Exp Res 30:720-730.
41. D'Herbomez M, Bauters C, Schlienger JL, Baldet T, Wémeau JL, Caron P 2006 Reference ranges of serum calcitonin in humans: influence of sex, age and cigarette smoking. Abstract to the European Thyroid Association, September 2-6, Napoli, Italy.